metformin has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, R; Gao, J; Guo, L; Hou, H; Li, B; Liu, X; Quan, M; Sun, Y; Tian, T | 1 |
1 other study(ies) available for metformin and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Topics: Analysis of Variance; Animals; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Hypoglycemic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Metformin; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Peptide Fragments; RNA, Messenger; T-Lymphocytes, Regulatory; Th17 Cells | 2016 |